291 related articles for article (PubMed ID: 36233650)
1. Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards
von Groote T; Meersch-Dini M
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233650
[TBL] [Abstract][Full Text] [Related]
2. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
3. Precision medicine in pediatric sepsis.
Atreya MR; Wong HR
Curr Opin Pediatr; 2019 Jun; 31(3):322-327. PubMed ID: 31090572
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of sepsis and precision-medicine-based immunotherapy.
Giamarellos-Bourboulis EJ; Aschenbrenner AC; Bauer M; Bock C; Calandra T; Gat-Viks I; Kyriazopoulou E; Lupse M; Monneret G; Pickkers P; Schultze JL; van der Poll T; van de Veerdonk FL; Vlaar APJ; Weis S; Wiersinga WJ; Netea MG
Nat Immunol; 2024 Jan; 25(1):19-28. PubMed ID: 38168953
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarkers used for risk estimation of pediatric sepsis-associated organ dysfunction and immune dysregulation.
Jariyasakoolroj T; Chattipakorn SC; Chattipakorn N
Pediatr Res; 2024 Jun; ():. PubMed ID: 38834784
[TBL] [Abstract][Full Text] [Related]
7. Using l-Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis.
Jennaro TS; Puskarich MA; McCann MR; Gillies CE; Pai MP; Karnovsky A; Evans CR; Jones AE; Stringer KA
Pharmacotherapy; 2020 Sep; 40(9):913-923. PubMed ID: 32688453
[TBL] [Abstract][Full Text] [Related]
8. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
Rello J; van Engelen TSR; Alp E; Calandra T; Cattoir V; Kern WV; Netea MG; Nseir S; Opal SM; van de Veerdonk FL; Wilcox MH; Wiersinga WJ
Clin Microbiol Infect; 2018 Dec; 24(12):1264-1272. PubMed ID: 29581049
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine in sepsis and septic shock: From omics to clinical tools.
Ruiz-Rodriguez JC; Plata-Menchaca EP; Chiscano-Camón L; Ruiz-Sanmartin A; Pérez-Carrasco M; Palmada C; Ribas V; Martínez-Gallo M; Hernández-González M; Gonzalez-Lopez JJ; Larrosa N; Ferrer R
World J Crit Care Med; 2022 Jan; 11(1):1-21. PubMed ID: 35433311
[TBL] [Abstract][Full Text] [Related]
10. Navigating the Landscape of Hydrocortisone Administration in Septic Shock: Current Concepts and Future Directions.
Kommareddy A; Vagha JD; Meshram RJ
Cureus; 2023 Dec; 15(12):e49870. PubMed ID: 38169849
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Estimating Risk of Hospital Mortality and Long-Term Quality-of-Life Morbidity After Surviving Pediatric Septic Shock: A Secondary Analysis of the Life After Pediatric Sepsis Evaluation Investigation.
Wong HR; Reeder RW; Banks R; Berg RA; Meert KL; Hall MW; McQuillen PS; Mourani PM; Chima RS; Sorenson S; Varni JW; McGalliard J; Zimmerman JJ;
Pediatr Crit Care Med; 2021 Jan; 22(1):8-15. PubMed ID: 33003178
[TBL] [Abstract][Full Text] [Related]
12. Sepsis endotypes identified by host gene expression across global cohorts.
Chenoweth JG; Brandsma J; Striegel DA; Genzor P; Chiyka E; Blair PW; Krishnan S; Dogbe E; Boakye I; Fogel GB; Tsalik EL; Woods CW; Owusu-Ofori A; Oppong C; Oduro G; Vantha T; Letizia AG; Beckett CG; Schully KL; Clark DV
Commun Med (Lond); 2024 Jun; 4(1):120. PubMed ID: 38890515
[TBL] [Abstract][Full Text] [Related]
13. Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review.
Önal U; Valenzuela-Sánchez F; Vandana KE; Rello J
Healthcare (Basel); 2018 Sep; 6(3):. PubMed ID: 30177659
[TBL] [Abstract][Full Text] [Related]
14. Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.
Coopersmith CM; De Backer D; Deutschman CS; Ferrer R; Lat I; Machado FR; Martin GS; Martin-Loeches I; Nunnally ME; Antonelli M; Evans LE; Hellman J; Jog S; Kesecioglu J; Levy MM; Rhodes A
Crit Care Med; 2018 Aug; 46(8):1334-1356. PubMed ID: 29957716
[TBL] [Abstract][Full Text] [Related]
15. Clinical review: sepsis and septic shock--the potential of gene arrays.
Wong HR
Crit Care; 2012 Feb; 16(1):204. PubMed ID: 22316118
[TBL] [Abstract][Full Text] [Related]
16. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model.
Wong HR; Caldwell JT; Cvijanovich NZ; Weiss SL; Fitzgerald JC; Bigham MT; Jain PN; Schwarz A; Lutfi R; Nowak J; Allen GL; Thomas NJ; Grunwell JR; Baines T; Quasney M; Haileselassie B; Lindsell CJ
Sci Transl Med; 2019 Nov; 11(518):. PubMed ID: 31723040
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific association of oxidative stress and immune response in septic shock mortality using NMR-based metabolomics.
Pandey S; Siddiqui MA; Trigun SK; Azim A; Sinha N
Mol Omics; 2022 Feb; 18(2):143-153. PubMed ID: 34881387
[No Abstract] [Full Text] [Related]
18. A Precision Medicine Approach to Biomarker Utilization in Pediatric Sepsis-Associated Acute Kidney Injury.
Odum JD; Wong HR; Stanski NL
Front Pediatr; 2021; 9():632248. PubMed ID: 33937146
[TBL] [Abstract][Full Text] [Related]
19. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study.
Scicluna BP; van Vught LA; Zwinderman AH; Wiewel MA; Davenport EE; Burnham KL; Nürnberg P; Schultz MJ; Horn J; Cremer OL; Bonten MJ; Hinds CJ; Wong HR; Knight JC; van der Poll T;
Lancet Respir Med; 2017 Oct; 5(10):816-826. PubMed ID: 28864056
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
